Welcome to LookChem.com Sign In|Join Free

CAS

  • or

104201-65-2

Post Buying Request

104201-65-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

104201-65-2 Usage

Role

Chemical Intermediate

Usage

Manufacturing of polymers, resins, and coatings

Toxicity Level

Moderate

Effects

Irritation to skin, eyes, and respiratory system

Handling Precautions

Should be handled and used with caution

Safety Protocols

Must be used in accordance with proper safety protocols

This compound serves as a crucial intermediate in various chemical synthesis processes, particularly in the production of polymers, resins, and coatings. However, its moderate toxicity necessitates careful handling to avoid skin, eye, and respiratory irritation, emphasizing the importance of adhering to safety protocols during its use.

Check Digit Verification of cas no

The CAS Registry Mumber 104201-65-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,4,2,0 and 1 respectively; the second part has 2 digits, 6 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 104201-65:
(8*1)+(7*0)+(6*4)+(5*2)+(4*0)+(3*1)+(2*6)+(1*5)=62
62 % 10 = 2
So 104201-65-2 is a valid CAS Registry Number.

104201-65-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name methyl (2E)-3-(2-fluorophenyl)prop-2-enoate

1.2 Other means of identification

Product number -
Other names methyl (E)-3-(2-fluorophenyl)-2-propenoate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:104201-65-2 SDS

104201-65-2Relevant articles and documents

Enantioselective Synthesis of Pyroglutamic Acid Esters from Glycinate via Carbonyl Catalysis

Ma, Jiguo,Zhou, Qinghai,Song, Guanshui,Song, Yongchang,Zhao, Guoqing,Ding, Kuiling,Zhao, Baoguo

supporting information, p. 10588 - 10592 (2021/04/06)

Direct α-functionalization of NH2-free glycinates with relatively weak electrophiles such as α,β-unsaturated esters still remains a big challenge in organic synthesis. With chiral pyridoxal 5 d as a carbonyl catalyst, direct asymmetric conjugated addition at the α-C of glycinate 1 a with α,β-unsaturated esters 2 has been successfully realized, to produce various chiral pyroglutamic acid esters 4 in 14–96 % yields with 81–97 % ee's after in situ lactamization. The trans and cis diastereomers can be obtained at the same time by chromatography and both of them can be easily converted into chiral 4-substituted pyrrolidin-2-ones such as Alzheimer's drug Rolipram (11) with the same absolute configuration via tert-butyl group removal and subsequent Barton decarboxylation.

Reduction of Electron-Deficient Alkenes Enabled by a Photoinduced Hydrogen Atom Transfer

Larionova, Natalia A.,Ondozabal, Jun Miyatake,Cambeiro, Xacobe C.

supporting information, p. 558 - 564 (2020/12/07)

Direct hydrogen atom transfer from a photoredox-generated Hantzsch ester radical cation to electron-deficient alkenes has enabled the development of an efficient formal hydrogenation under mild, operationally simple conditions. The HAT-driven mechanism is supported by experimental and computational studies. The reaction is applied to a variety of cinnamate derivatives and related structures, irrespective of the presence of electron-donating or electron-withdrawing substituents in the aromatic ring and with good functional group compatibility. (Figure presented.).

HETEROCYCLIC COMPOUNDS FOR MODULATING NR2F6

-

Paragraph 00393; 00405, (2021/09/04)

The present disclosure relates to compounds capable of modulating the activity of NR2F6. The compounds of the disclosure may be used in methods for the prevention and/or the treatment of diseases and disorders associated with modulating NR2F6 activity.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 104201-65-2